Visit Raven

Generic Semaglutide is coming to Canada

Generic semaglutide is coming to Canada. When it arrives, you can expect the same active ingredient as Ozempic and Wegovy at a fraction of the cost. We'll let you know the moment it's available through Raven.

Frequently asked questions

What is a generic medication?

Generic drugs are authorized by Health Canada to contain the exact same active ingredient as the original brand. Same mechanism. Same therapeutic effect. Just a different manufacturer and a lower price tag.

Why will it be cheaper?

Canada has a pricing framework that drives costs down as more generics enter the market. The more manufacturers approved, the more the price falls.

Is it as safe as Ozempic or Wegovy?

Yes. Health Canada holds generics to the same safety, quality, and manufacturing standards as the original.

When will generic semaglutide be available in Canada?

The exact timing is still uncertain, but approvals are expected in 2026. Availability may be limited at first as manufacturers scale up production. We'll update you as soon as it's available through Raven.

Will Raven carry generic semaglutide?

Yes. Sign up above and you'll be the first to know when it's live.

Will it work the same way?

Generic semaglutide contains the same active ingredient as Ozempic and Wegovy and is required to produce the same therapeutic effect. Health Canada authorization means it has met the same standards.

What about Mounjaro and other GLP-1s?

Only semaglutide is going off-patent right now, so lower pricing applies to semaglutide-based medications specifically. Other GLP-1s aren't expected to be affected by this change.

Do I need to be an existing Raven patient to access it?

No. If you're new to Raven, you'll complete a brief online assessment so a Canadian clinician can review your health history and confirm it's the right fit for you.